OBESITY, PHYSICAL INACTIVITY AND SYMPTOMS AFTER OVARIAN CANCER TREATMENT: RESULTS FROM AN INTERNATIONAL INTERNET-BASED SURVEY
Webber K. et al, (2015), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 25, 42 - 43
Restaging Oesophageal Cancer Following Neoadjuvant Chemotherapy With Pet-Ct, and Prediction Of Progression to Unresectable Disease
Findlay J. et al, (2015), BRITISH JOURNAL OF SURGERY, 102, 7 - 7
Selective Staging of Oesophageal and Gastro-Oesophageal Junctional Cancer with Endoscopic Ultrasound, Positron Emission Tomography and Laparoscopy
Findlay J. et al, (2015), BRITISH JOURNAL OF SURGERY, 102, 34 - 35
Studying epigenomics in single cells: what is feasible and what can we learn?
Wills QF. et al, (2015), Epigenomics, 7, 1231 - 1234
A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Collins GP. et al, (2014), BLOOD, 124
Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML
Chowdhury O. et al, (2014), BLOOD, 124
Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders
Hamblin A. et al, (2014), BLOOD, 124
Eltrombopag Mobilizes Intracellular Iron Stores at Concentrations Lower Than Those Required with Other Clinically Available Iron Chelators
Koumoutsea EV. et al, (2014), BLOOD, 124
Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34-Human Acute Myeloid Leukemia
Quek L. et al, (2014), BLOOD, 124
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA. et al, (2014), Eur J Haematol, 93, 455 - 468
Avid nodal stage of oesophageal cancer and metabolic response to neoadjuvant chemotherapy: novel Methods of predicting progression to metastatic disease
Findlay J. et al, (2014), BRITISH JOURNAL OF SURGERY, 101, 35 - 36
Decision theory and cost-benefit analysis of re-staging oesophageal cancer with PET-CT after neoadjuvant chemotherapy
Findlay J. et al, (2014), BRITISH JOURNAL OF SURGERY, 101, 51 - 52
Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB. et al, (2014), Am J Hematol, 89, E228 - E234
Exome sequencing of oesophageal adenocarcinoma demonstrates novel driver genes and pathways of carcinogenesis and response to neoadjuvant chemotherapy
Findlay J. et al, (2014), BRITISH JOURNAL OF SURGERY, 101, 47 - 47
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer.
Blagden S. et al, (2014), Clin Cancer Res, 20, 5908 - 5917
Gene set enrichment analysis of genome wide association data identifies novel biological pathways associated with Barrett's Oesophagus, and subsequent progression to dysplasia and adenocarcinoma
Findlay J. et al, (2014), BRITISH JOURNAL OF SURGERY, 101, 50 - 50
Genomic biomarkers of Barrett's Oesophagus metaplasia, dysplasia and malignant progression: a meta-analysis
Findlay J. et al, (2014), BRITISH JOURNAL OF SURGERY, 101, 39 - 39
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
Corcoran JP. et al, (2014), Br J Hosp Med (Lond), 75, 652 - 653
Clinical pharmacokinetics (PK), translational PK/pharmacodynamics (PD), and exposure-adverse events (AEs) relationship of MLN2480, an oral investigational pan-RAF kinase inhibitor
Zhou X. et al, (2014), EUROPEAN JOURNAL OF CANCER, 50, 105 - 106
First-in-human phase 1 study of MLN2480, an investigational oral pan-RAF kinase inhibitor, in patients (pts) with relapsed or refractory solid tumors, including BRAF/NRAS-mutant melanoma
Middleton M. et al, (2014), EUROPEAN JOURNAL OF CANCER, 50, 117 - 117